AstraZeneca to invest $2 billion as part of US manufacturing push

0
89
AstraZeneca said on Friday it will invest $2 billion to expand its manufacturing footprint in Maryland as part of its previously announced $50 billion plan to expand manufacturing and research capabilities in the U.S. by 2030.

Read more…

LEAVE A REPLY

Please enter your comment!
Please enter your name here